Synergy CHC Corp.

SNYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2014
Revenue $9.2K
Cost of Revenue $5.6K
Gross Profit $3.5K
Gross Margin 38.7%
Operating Expenses
Research & Development
SG&A Expense $961.6K
Operating Income $-958.1K
Operating Margin -10,461.8%
Interest Expense $2.0K
Pretax Income $-960.1K
Income Tax Expense $0
Net Income $-960.1K
Net Margin -10,483.6%
EPS (Basic) $-0.01
EPS (Diluted) $-0.01
Shares Outstanding (Basic) 62.1M
Shares Outstanding (Diluted) 62.1M
Dividends Per Share
← Newer Page 2 of 2 Older →